Empa researcher Peter Nirmalraj analyzes blood samples using atomic force microscopy (AFM). Image: Empa
Empa researcher Peter Nirmalraj analyzes blood samples using atomic force microscopy (AFM). Image: Empa - Empa researcher Peter Nirmalraj wants to image proteins with unprecedented precision - and thus gain insights into the molecular pathogenesis of Alzheimer's. This should pave the way for an earlier diagnosis of the dementia disorder via a simple blood test. Together with neurologists from the Kantonsspital St.Gallen, a successful pilot study has now been completed. If the suspicion of Alzheimer's disease creeps up, those affected must prepare themselves for lengthy and complex procedures until the case is clear. A team from Empa and the Cantonal Hospital of St. Gallen is now in the process of developing a blood test that will enable a reliable diagnosis using atomic force microscopy (AFM). The researchers have recently published their first results of a successful pilot study Advances.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
